• Firm whose stock surged 1000% in 2020 starts human trials of Covid-19 vaccine

    Firm whose stock surged 1000% in 2020 starts human trials of Covid-19 vaccine

    Published Date : 26-May-2020 4:23:38 IST

    US biotech company Novavax said it has started Phase 1 clinical trial of its experimental coronavirus vaccine and has enrolled 130 volunteers. Novavax’s valuation has surged by over 1,000% this year to about $2.7 billion despite having no products on the market. The trial is being supported by $388 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI).

Related Posts